|
|
||||||||
Ann Thorac Surg 2006;82:1171
© 2006 The Society of Thoracic Surgeons
a Divisions of Gastroenterologic and General Surgery, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905
b Division of General Thoracic Surgery, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905
(Email: houghton.scott@mayo.edu; allen.mark@mayo.edu; sarr.michael@mayo.edu).
| The first 20% of the full text of this article appears below. |
To the Editor:
We were intrigued by the case report by Chen and colleagues [1]. Although we agree that gastroesophageal reflux disease (GERD) impacts many obese patients [2, 5], performing an anti-reflux operation after Roux-en-Y gastric bypass (RYGB) seems counterintuitive. When performed correctly, RYGB decreases dramatically and virtually eliminates acid present in the proximal gastric pouch, reduces GERD symptoms, DeMeester scores, and use of anti-reflux medications, and should eliminate completely duodeno-esophageal reflux by the Roux anatomy [2, 3, 4, 6]. After RYGB, reflux symptoms improve dramatically (and immediately postoperatively) prior to weight loss,
Related Article
Ann. Thorac. Surg. 2006 82: 1172.
This article has been cited by other articles:
![]() |
D. B. Lautz and R. Bueno Reply. Ann. Thorac. Surg., September 1, 2006; 82(3): 1172 - 1172. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |